This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPED2T082_M.jpg
Alx Oncology Holdings (NASDAQ:ALXO) 18% HIGHER; announced the hosting of an investor call and webcast on Tuesday, October 3rd at 8:00 AM EDT to share interim Phase 2 ASPEN-06 clinical trial results of evorpacept for the treatment of advanced HER2-positive gastric cancer.
Biohaven Pharmaceutical Holding Co Ltd (NYSE:BHVN) 5% LOWER; announced that it has commenced an underwritten public offering of $200 million of its common shares
Sculptor Capital Management, Inc. (NYSE:SCU) 5% HIGHER; Weinstein raises sculptor bid anew as Rithm weighs higher offer – Bloomberg.
ProMIS Neurosciences Inc (NASDAQ:PMN) 5% HIGHER; BTIG initiates coverage with a Buy rating and a price target of $8.00.
Applied Digital Corp (NASDAQ:APLD) 4% HIGHER; Roth/MKM initiates coverage with a Buy rating and a price target of $14.00.
Gaia, Inc. (NASDAQ:GAIA) 2% LOWER; intends to offer shares of its Class A common stock for sale in an underwritten public offering at a proposed public offering price per share that is greater than today’s closing price for the Company’s Class A common stock.
